Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Fuhr

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Clinical Pharmacology and Therapeutics|February 16, 2007
Plasma and tissue pharmacokinetics of epirubicin and Paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancerM Hunz, A Jetter, M Warm, et al.
European Journal of Clinical Pharmacology|July 1, 2008
No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolamD Tomalik-Scharte, O Doroshyenko, J Kirchheiner, et al.
Clinical Pharmacology and Therapeutics|April 9, 2010
Pharmacokinetic/pharmacodynamic modeling of biomarker response to sunitinib in healthy volunteersA Lindauer, P Di Gion, F Kanefendt, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 30, 1998
Grapefruit juice increases oral nimodipine bioavailabilityU Fuhr, A Maier-Brüggemann, H Blume, et al.
European Journal of Clinical Pharmacology|June 11, 2005
Dermal absorption of permethrin following topical administrationD Tomalik-Scharte, A Lazar, J Meins, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2009
Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantationV Kohl, C Müller, O A Cornely, et al.
Cancer Chemotherapy and Pharmacology|August 6, 2015
Pharmacokinetics and pharmacogenetics of capecitabine and its metabolites following replicate administration of two 500 mg tablet formulationsChristian Queckenberg, V Erlinghagen, B C M Baken, et al.
European Journal of Clinical Pharmacology|January 31, 2012
Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndromeJ J Vehreschild, C Müller, F Farowski, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 1, 2003
The role of active metabolites in dihydrocodeine effectsH Schmidt, S V Vormfelde, M Walchner-Bonjean, et al.
Molecular Pharmacology|February 1, 1993
Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2U Fuhr, G Strobl, F Manaut, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Clinical Pharmacology and Therapeutics|February 16, 2007
Plasma and tissue pharmacokinetics of epirubicin and Paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancerM Hunz, A Jetter, M Warm, et al.
European Journal of Clinical Pharmacology|July 1, 2008
No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolamD Tomalik-Scharte, O Doroshyenko, J Kirchheiner, et al.
Clinical Pharmacology and Therapeutics|April 9, 2010
Pharmacokinetic/pharmacodynamic modeling of biomarker response to sunitinib in healthy volunteersA Lindauer, P Di Gion, F Kanefendt, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 30, 1998
Grapefruit juice increases oral nimodipine bioavailabilityU Fuhr, A Maier-Brüggemann, H Blume, et al.
European Journal of Clinical Pharmacology|June 11, 2005
Dermal absorption of permethrin following topical administrationD Tomalik-Scharte, A Lazar, J Meins, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2009
Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantationV Kohl, C Müller, O A Cornely, et al.
Cancer Chemotherapy and Pharmacology|August 6, 2015
Pharmacokinetics and pharmacogenetics of capecitabine and its metabolites following replicate administration of two 500 mg tablet formulationsChristian Queckenberg, V Erlinghagen, B C M Baken, et al.
European Journal of Clinical Pharmacology|January 31, 2012
Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndromeJ J Vehreschild, C Müller, F Farowski, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 1, 2003
The role of active metabolites in dihydrocodeine effectsH Schmidt, S V Vormfelde, M Walchner-Bonjean, et al.
Molecular Pharmacology|February 1, 1993
Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2U Fuhr, G Strobl, F Manaut, et al.
Pageof 9